ProPublica interviewed senior officials at five federal agencies to understand the repercussions.
The Big Story
Sat. Jun 20, 2020
Despite Trump’s declared exit from the WHO, officials continued working toward reforms and to prevent withdrawal. This week, they were told they must justify any cooperation with the WHO on the grounds of national security and public health safety.
VIEW STORY
More From Our Newsroom
Prison overcrowding has been quietly tolerated for decades. But the pandemic is forcing a reckoning.
The plastic tubes supplied for coronavirus testing by Fillakit, a first-time federal contractor with a sketchy owner, don’t even fit the racks used to analyze samples. And they may be contaminated anyway.
Everything Mary Savage did in the hours after the attack was dissected on the witness stand, an experience so upsetting she vomited. But years later, she finds comfort knowing her testimony led to his conviction.
Among the many ways to shorten the vaccine development timeline, approving a treatment based on antibody data — without completing a phase 3 trial — could be contentious. This is why.
It is likely we’ll eventually have a coronavirus vaccine — but perhaps not as quickly as some expect. From development, to clinical trials and distribution, ProPublica reporter Caroline Chen explains the tremendous challenges that lie ahead.
A nursing home in Troy, New York, followed the governor’s order to accept patients being treated for COVID-19. Six weeks later, 18 residents were dead of the disease.
 
Was this email forwarded to you from a friend? Subscribe.
This email was sent to [email protected]. Update your email preferences or unsubscribe to stop receiving this newsletter. Email not displaying correctly? View it in your browser.